Additive Toxicity of β-Amyloid by a Novel Bioactive Peptide In Vitro: Possible Implications for Alzheimer’s Disease

Garcia-Ratés, Sara; Lewis, Matthew; Worrall, Rosemary; Greenfield, Susan
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: β-amyloid is regarded as a significant factor in Alzheimer’s disease: but inefficient therapies based on this rationale suggests that additional signalling molecules or intermediary mechanisms must be involved in the actual initiation of the characteristic degeneration of neurons. One clue could be that acetylcholinesterase, also present in amyloid plaques, is aberrant in peripheral tissues such as blood and adrenal medulla that can be implicated in Alzheimer’s disease. The aim of this study was to assess the bioactivity of a fragment of acetylcholinesterase responsible for its non-enzymatic functions, a thirty amino acid peptide (“T30”) which has homologies with β-amyloid. Methods: Cell viability was measured by sulforhodamine B assay and also lactate dehydrogenase assay: meanwhile, changes in the status of living cells was monitored by measuring release of acetylcholinesterase in cell perfusates using the Ellman reagent. Findings: T30 peptide and β-amyloid each have toxic effects on PC12 cells, comparable to hydrogen peroxide. However only the two peptides selectively then evoke a subsequent, enhanced release in acetylcholinesterase that could only be derived from the extant cells. Moreover, unlike hydrogen peroxide, the T30 peptide selectively shifted a sub-threshold dose of β-amyloid to a toxic effect, which also resulted in a comparable enhanced release of acetylcholinesterase. Interpretation: This is the first study comparing directly the bioactivity of β-amyloid with a peptide derived from acetylcholinesterase: the similarity in action suggests that the sequence homology between the two compounds might have a functional and/or pathological relevance. The subsequent enhanced release of acetylcholinesterase from the extant cells could reflect a primary ‘compensatory’ response of cells prone to degeneration, paradoxically providing further availability of the toxic C-terminal peptide to modulate the potency of β-amyloid. Such a cycle of events may provide new insights into the mechanism of continuing selective cell loss in Alzheimer’s disease and related degenerative disorders.


Related Articles

  • Protective Effects of Astragaloside IV against Amyloid Beta1-42 Neurotoxicity by Inhibiting the Mitochondrial Permeability Transition Pore Opening. Sun, Qinru; Jia, Ning; Wang, Weixi; Jin, Hui; Xu, Jiehua; Hu, Haitao // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Mitochondrial dysfunction caused by amyloid β-peptide (Aβ) plays an important role in the pathogenesis of Alzheimer disease (AD). Substantial evidence has indicated that the mitochondrial permeability transition pore (mPTP) opening is involved in Aβ-induced neuronal death and reactive...

  • Alpha-Secretase Cleavage of the Amyloid Precursor Protein: Proteolysis Regulated by Signaling Pathways and Protein Trafficking. F. Lichtenthaler, Stefan // Current Alzheimer Research;Feb2012, Vol. 9 Issue 2, p165 

    α-secretase is the name for a metalloprotease activity, which is assumed to play a key role in the prevention of the molecular mechanisms underlying Alzheimer's disease (AD). Proteases similar to α-secretase are essential for a wide range of biological processes, such as cell adhesion and...

  • The AICD Interacting Protein DAB1 is Up-Regulated in Alzheimer Frontal Cortex Brain Samples and Causes Deregulation of Proteins Involved in Gene Expression Changes. Müller, T.; Loosse, C.; Schrötter, A.; Schnabel, A.; Helling, S.; Egensperger, R.; Marcus, K. // Current Alzheimer Research;Aug2011, Vol. 8 Issue 5, p573 

    AICD is the intracellular subdomain of the amyloid precursor protein thought to play a pivotal role as a potential transcription factor that might be of relevance for the pathophysiology of Alzheimer's disease. For its signal transduction potential AICD requires interacting proteins like FE65...

  • Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons. Brito-Moreira, J.; Paula-Lima, A. C.; Bomfim, T. R.; Oliveira, F. F.; Sepúlveda, F. J.; De Mello, F. G.; Aguayo, L. G.; Panizzutti, R.; Ferreira, S. T. // Current Alzheimer Research;Aug2011, Vol. 8 Issue 5, p552 

    Soluble oligomers of the amyloid-β peptide (AβOs) accumulate in Alzheimer's disease (AD) brain and have been implicated in mechanisms of pathogenesis. The neurotoxicity of AβOs appears to be, at least in part, due to dysregulation of glutamate signaling. Here, we show that AβOs...

  • The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease. Inestrosa, Nibaldo C.; Toledo, Enrique M. // Molecular Neurodegeneration;2008, Vol. 3, Special section p1 

    Recent evidence supports a neuroprotective role for Wnt signaling in neurodegenerative disorders such as Alzheimer's Disease (AD). In fact, a relationship between amyloid-β-peptide (Aβ)-induced neurotoxicity and a decrease in the cytoplasmic levels of β-catenin has been observed....

  • Reciprocal Induction Between α-Synuclein and β-Amyloid in Adult Rat Neurons. Majd, Shohreh; Chegini, Fariba; Chataway, Tim; Zhou, Xin-Fu; Gai, Weiping // Neurotoxicity Research;Jan2013, Vol. 23 Issue 1, p69 

    In spite of definite roles for β-amyloid (Aβ) in familial Alzheimer's disease (AD), the cause of sporadic AD remains unknown. Amyloid senile plaques and Lewy body pathology frequently coexist in neocortical and hippocampal regions of AD and Parkinson's diseases. However, the relationship...

  • Resveratrol Inhibits β-Amyloid-Induced Neuronal Apoptosis through Regulation of SIRT1-ROCK1 Signaling Pathway. Feng, Xiaowen; Liang, Nan; Zhu, Dexiao; Gao, Qing; Peng, Lei; Dong, Haiman; Yue, Qingwei; Liu, Haili; Bao, Lihua; Zhang, Jing; Hao, Jing; Gao, Yingmao; Yu, Xuejie; Sun, Jinhao // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Alzheimer’s disease (AD) is characterized by the accumulation of β-amyloid peptide (Aβ) and loss of neurons. Recently, a growing body of evidences have indicated that as a herbal compound naturally derived from grapes, resveratrol modulates the pathophysiology of AD, however, with a...

  • Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance. Balaraman, Y.; Limaye, A. R.; Levey, A. I.; Srinivasan, S. // Cellular & Molecular Life Sciences;Jun2006, Vol. 63 Issue 11, p1226 

    Alzheimer’s disease (AD) is a neurodegenerative disorder associated with cognitive and behavioral dysfunction and is the leading cause of dementia in the elderly. Several studies have implicated molecular and cellular signaling cascades involving the serine-threonine kinase, glycogen...

  • Hijacking PrPc-dependent signal transduction: when prions impair Aβ clearance. Hernandez-Rapp, Julia; Martin-Lannerée, Séverine; Hirsch, Théo Z.; Launay, Jean-Marie; Mouillet-Richard, Sophie // Frontiers in Aging Neuroscience;Mar2014, Vol. 6, p1 

    The cellular prion protein PrPc is the normal counterpart of the scrapie prion protein PrPSc, the main component of the infectious agent of transmissible spongiform encephalopathies. The recent discovery that PrPc can serve as a receptor for the amyloid beta (Aβ) peptide and relay its...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics